Awaiting development: Guidance and quality standards
Showing 1 to 6 of 6
| Title | Type |
|---|---|
| Canagliflozin for treating type 2 diabetes in people 10 to 17 years [TSID11888] | Technology appraisal guidance |
| Dulaglutide for treating type 2 diabetes [ID1451] | Technology appraisal guidance |
| Semaglutide for treating type 2 diabetes [ID1450] | Technology appraisal guidance |
| Sotagliflozin for treating type 2 diabetes [ID1657] | Technology appraisal guidance |
| Tirzepatide for treating type 2 diabetes in people 10 to 17 years [ID6539] | Technology appraisal guidance |
| Zimislecel for treating type 1 diabetes in people 12 years and over with impaired hypoglycaemic awareness and severe hypoglycaemia [ID6624] | Technology appraisal guidance |